08.09.2017 • NewsDede Willamssiliconesspecialty silicones

Evonik starts up China Silicones Plant

(c) Evonik
(c) Evonik

Evonik has started up a new plant for organically modified specialty silicones at Shanghai, China, strengthening its business with the products used in applications such as polyurethanes as well as paints and coatings and a variety of industrial applications.

Speaking at the plant’s inauguration, CEO Christian Kullmann, said it is another important cornerstone in Evonik’s strategy to “focus on businesses with a clear orientation toward specialty chemicals and on powerful innovations to significantly increase the value of the company.”

Organically modified specialty silicones, part of the Essen-based group’s specialty additives business, are one of four growth engines for which it sees above-average earnings potential. The Chinese facility will meet rising demand for specialty silicones in China and neighboring countries and at the same time consolidate Evonik’s position as the global market and technology leader for organically modified specialty silicones, Kullmann said.

The new production facility, which cost a “high two-digit million” euro figure, has simplified supply chain, the chemical producer said. By producing specialty silicones locally, it will no longer have to ship to Asia from Europe or North America and can thus react faster to requests, said Claus Rettig, head ofthe group’s Resource Efficiency segment.

Evonik has been active in China for more than decades. With the takeover of the specialty additives business of Air Products at the beginning of 2017 and the opening of new plants in Nanjing, it recently has significantly expanded its business in the region.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.